Skip to main content
. 2017 Feb 16;35(5):608–615. doi: 10.1007/s10637-017-0441-4

Fig. 1.

Fig. 1

Time dependent change, relative to pretreatment, of the chemotrypsin-like activity (CLA) in isolated PBMC from patients receiving 20/27, 20/36, and 2045 mg/m2 carfilzomib. Data are represented as the geometric mean and 95%CI of the ratio of CLA relative to the pretreatment value